Bibliography
- Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease. Arterioscl Thromb Vascul Biol 2008;28:166-72
- Rantner B, Kollertis B, Anderwald-Stadler M, et al. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study. Clin Chem 2008;54:851-7
- Breimer LH, Spyropolous KA, Winder AF, et al. Is bilirubin protective against coronary artery disease? Clin Chem 1994;40:1987-8
- Ishizaka N, Ishizaka Y, Takahashi E, et al. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 2001;32:580-3
- Perlstein TS, Pande RL, Creager MA, et al. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999 – 2004. Am J Med 2008;121:781-8
- Krijgsman B, Papadakis JA, Ganotakis ES, et al. The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin. Int Angiol 2002;21:44-52
- Papadakis JA, Ganotakis ES, Jagroop IA, et al. Effect of hypertension and its treatment on lipid, lipoprotein (a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia. Am J Hypertens 1999;12:673-81
- Ganotakis ES, Vrentzos GE, Gazi IF, et al. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo 2007;2:685-94
- Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994;40:18-23
- Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007;43:1-57
- Burtis CA, Ashwood ER, editors, Tietz Textbook of Clinical Chemistry, 3rd edition. WB Saunders & Co; Philadelphia, PA, USA; 1999